The serum titers of nAChR Abs against MIR, determined by the mAb35 inhibition assay, tend to correlate with disease severity in patients with MG [54], suggesting the significance of MIR-specific nAChR Abs (e.g., human B12L) in the pathogenesis. Here, CHRNA4 is linked to myasthenia gravis.